文献速递认知障碍与痴呆

脂肪组织中的神经毒性化学物质:解释肥胖与痴呆矛盾关联的新视角

Neurotoxic chemicals in adipose tissue: A role in puzzling findings on obesity and dementia.
PubMed 文献 · Neurology · 2018-01-01

中年肥胖增加痴呆风险,而晚年肥胖常与较低痴呆风险相关,此矛盾现象可能与脂肪组织中储存的有机氯农药(OCPs)有关。OCPs为强亲脂性、半衰期长的神经毒性化学物,血清浓度与脑内浓度高度相关(r=0.95)。脂肪细胞功能障碍或体重减轻可释放OCPs入循环增加痴呆风险,而体重增加可能封存OCPs,此假说有待实验和人群研究验证。

要点

  • 中年肥胖通过脂肪细胞功能障碍慢性释放OCPs入循环,增加痴呆风险。
  • 晚年体重减轻释放OCPs,而体重增加可能减少释放,影响痴呆风险。
  • 血清OCPs与脑内OCPs浓度高度相关(r=0.95),支持其神经毒性作用。

核心结论

  • 脂肪组织中储存的OCPs的释放差异可能解释中年与晚年肥胖对痴呆风险的反向关联。

研究设计与样本

  • 本文为假说性综述,未报告系统检索范围或样本量。

主要发现

  • 中年肥胖与痴呆风险增加相关,而晚年肥胖常与较低痴呆风险相关。
  • OCPs半衰期长达数年,主要储存于脂肪组织,血清与脑内浓度高度相关(r=0.95)。
  • 脂肪细胞功能障碍伴不受控脂解或体重减轻可增加OCPs释放入循环,体重增加可能封存循环OCPs。

关键数值与推荐

  • OCPs半衰期为数年,血清与脑内浓度相关系数r=0.95。
  • 中年肥胖可能通过慢性释放OCPs入循环增加痴呆风险;晚年体重变化影响OCPs释放方向。

临床怎么用

  • 临床评估肥胖与痴呆风险时,可考虑中年至晚年体重变化模式及OCPs暴露可能性。
  • 该假说尚未经实验或人群研究验证,不宜据此改变临床实践。

局限性

  • 本文为假说性论述,未提供原始实验或人群研究数据验证。
  • 未系统检索文献或报告样本量、置信区间等定量证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Midlife obesity is associated with increased risk of dementia, whereas late-life obesity is commonly associated with a lower risk of dementia. Although methodologic issues are often discussed in this apparent risk reversal, chronic exposure to low-dose organochlorine pesticides (OCPs), an emerging risk factor for dementia in general populations, may contribute to a direct explanation for these differences. OCPs are strong lipophilic chemicals with very long half-lives (several years), primarily stored in adipose tissue and very slowly released and metabolized over years. As serum concentrations of neurotoxic OCPs strongly correlate with brain OCPs (r = 0.95), any condition enhancing the release of OCPs from the adipose tissue into circulation would increase the risk of dementia. Increased release of OCPs from adipose tissue typically occurs in (1) dysfunctional adipocytes accompanied by uncontrolled lipolysis and (2) weight loss. Weight gain may help sequester circulating OCPs in adipose tissue. As obesity is the most common reason that adipocytes become dysfunctional, midlife obesity can increase dementia risk through the chronic release of OCPs into circulation. However, late-life obesity potentially decreases dementia risk because weight loss after midlife will increase the release of OCPs while weight gain may actually decrease the release. These countervailing forces may underlie paradoxical associations with dementia of obesity in midlife vs late life which is influenced by weight change after midlife. This hypothesis should be tested in future experimental and human studies on obesity and dementia.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lee DH, Porta M, Lind L, et al. Neurotoxic chemicals in adipose tissue: A role in puzzling findings on obesity and dementia. Neurology. 2018. PMID: 29358509. doi:10.1212/WNL.0000000000004851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。